RECORDATI CORPORATION

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,000. A European field force of over 1,000 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati’s current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company’s leading product. Consolidated revenue for 2005 was € 576.1 million, operating income was € 111.1 million and net income was € 64.5 million.

Contact Details: 502 Centennial AvenueP.O. Box 160 Cranford New Jersey 07016 United States of America Tel: 1 908 272 7220 Fax: 39 02 40073747 Email: comimagen@recordati.it WWW: www.recordati.it/

Loading...

Recent Publications by RECORDATI CORPORATION:
Spatial distribution of Helicobacter spp. in the gastrointestinal tract of dogs. BACKGROUND: In dogs, the gastric Helicobacter spp. have been well studied,...	16th October, 2009	Dipartimento di Patologia Animale, Igiene e Sanita Pubblica Veterinaria,	Helicobacter. 2009 Jun;14(3):180-91. DOI Direct Link
Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats. OBJECTIVE: To investigate the role of Group I metabotropic glutamate...	29th October, 2008	Pharmaceutical R & D Division, RECORDATI S.p.A., Milano, Italy.	BJU Int. 2008 Sep;102(7):890-8. Epub 2008 May 16. DOI Direct Link
A simple method for the production of bacterial controls for immunohistochemistry and fluorescent in situ hybridization. Immunohistochemical and fluorescent in situ hybridization (FISH) assays...	11th October, 2008	Dipartimento di Patologia Animale, Igiene e Sanita Pubblica Veterinaria,	J Mol Histol. 2008 Aug;39(4):459-62. Epub 2008 May 31. DOI Direct Link
The 24 h blood pressure-R-R interval relation in ambulatory monitoring. The present study was aimed at investigating whether the blood...	12th July, 2008	Centro Interuniversitario di Fisiologia Clinica ed Ipertensione ed	Auton Neurosci. 2008 May 30;139(1-2):68-77. Epub 2008 Mar 4. DOI Direct Link
Detection of Helicobacter spp. DNA in the oral cavity of dogs. The mode of acquisition of gastric Helicobacter spp. infection in dogs has...	1st November, 2007	Dipartimento di Patologia Animale, Igiene e Sanita Pubblica Veterinaria,	Vet Microbiol. 2007 Jan 31;119(2-4):346-51. Epub 2006 Sep 8. DOI Direct Link
→View more RECORDATI CORPORATION research publications.

BioNews Results for RECORDATI CORPORATION:
Recordati S.p.A: European Medicines Evaluation Agency Adopts A Positive Opinion For Silodosin (Brands Urorec(R	BioSpace:  Nov 21 2009 12:39AM Matching: recordati
Italian Recordati gets positive opinion on silodosin	ADP News:  Nov 21 2009 3:07AM Matching: recordati
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Silodyx	Pharma Live:  Nov 20 2009 5:12PM Matching: recordati
EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix	Lloyd's:  Nov 20 2009 3:08PM Matching: recordati
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Urorec	Pharma Live:  Nov 20 2009 2:30PM Matching: recordati
Promote your company here: BioNewsCast - Press Release Distribution	→View more RECORDATI CORPORATION news.

RECORDATI CORPORATION Patents:
US Patent No.	Title
4705797	N-(3,3-diphenylpropyl) aminoethyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid, compositions and use
5527545	Liquid-suspension controlled-release pharmaceutical composition
5571533	Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
5605896	Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergic and 5HT.sub.1A activities
5654476	Process for the preparation of gemfibrozil
→View more RECORDATI CORPORATION patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 13 individuals from RECORDATI CORPORATION using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 328 times since April 2007, the link to the organisation's website has been followed 45 times

Recent Search Terms used to find this page: recordati usa | .

Search for more companies in Cranford

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for RECORDATI CORPORATION